spacer
home > ict > autumn 2020 > accelerating processes and enhancing compliance with pharmacovigilance automation
PUBLICATIONS
International Clinical Trials

Accelerating Processes and Enhancing Compliance with Pharmacovigilance Automation

Adverse event (AE) information comes from healthcare professionals, manufacturers, and patients themselves, producing a huge volume of data to analyse. Life science organisations face a daily challenge capturing this information, assessing its significance, and reporting it to the authorities in a timely manner, so that safety information can be updated and, if appropriate, additional action can be taken.

It is clear that pharmaceutical companies should be harnessing the latest technology to capture and process the workloads. The range of technology options are considerable, and the technology is proven, reliable, and highly cost-efficient. However, it does appear that companies could be doing so much more with technology.

Many pharma companies believe they are making good use of technology for AE data capture and reporting, according to a recent survey. The research examines life science companies’ attitudes towards, and plans for, pharmacovigilance (PV) automation, particularly

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr John Price, owner and Managing Director of John Price PharmaSolutions LLC, is a life science regulatory and safety veteran and consultant, and an advisor to PV managed service provider Arriello.

drjsprice@pharmacovigilantes.com
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sartorius to Join the DAX Blue Chip Index

September 4, 2021 – The life science group Sartorius will be admitted to the German DAX blue chip index. After the market closes on September 17, 2021, Sartorius preference shares will be included in the calculation of the DAX, as Deutsche Börse announced on Friday evening.
More info >>

White Papers

Systems Engineering for Complex Portable Medical Device Development

Phillips-Medisize

As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount. Taking a systems-engineering (SE) approach to development provides a holistic, organized, and deliberate method for identifying as well as reducing both patient and business risks early in the process. Furthermore, it facilitates efficient progression throughout the entire product development life cycle.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement